Literature DB >> 5469783

Coumermycin A-biopharmaceutical studies. I.

H L Newmark, J Berger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5469783     DOI： 10.1002/jps.2600590905

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  2 in total

1.  Gyrase B inhibitor impairs HIV-1 replication by targeting Hsp90 and the capsid protein.

Authors:  Luciano Vozzolo; Belinda Loh; Paul J Gane; Maryame Tribak; Lihong Zhou; Ian Anderson; Elisabeth Nyakatura; Richard G Jenner; David Selwood; Ariberto Fassati
Journal:  J Biol Chem       Date:  2010-10-11       Impact factor: 5.157

2.  Activity of coumermycin against clinical isolates of staphylococci.

Authors:  M N Guillemin; H M Miles; M I McDonald
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.